Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Inhaler training boosts medication adherence in seniors

NCT ID NCT07381166

Symptom relief Sponsor: Çanakkale Onsekiz Mart University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving elderly patients special training and reminder cards helps them use their metered-dose inhalers correctly and stick to their medication schedule. Researchers will enroll 64 people aged 65 and older who already use inhalers. The goal is to see if simple education and reminders can improve inhaler technique and medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Metered-dose inhaler training and reminder card
What this could lead to
If successful, this approach could help elderly patients use their inhalers more correctly and take their medication as prescribed, potentially improving breathing and quality of life.
What could go wrong
This is a small, early-stage study with only 64 participants, so results may not apply to all elderly patients. The intervention is educational, not a new drug, so it won't cure any lung disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for the study: * Age ≥ 65 years old * Having at least basic literacy, * Receiving metered-dose inhaler therapy for at least 6 months, * Being hospitalized in the pulmonary ward, * Presenting to the pulmonary function test unit, * Presenting to the pulmonary outpatient clinic, * Signing the informed consent form for participation in the study, * Having internet access and a mobile device with Android/iOS operating system, * Being able to use a telephone, * Having no communication barriers, * Being able to use the inhaler without needing assistance, * Making an error in at least one of the usage steps according to the MDI usage skills chart. Exclusion criteria for the study: * Age \<65 * Illiteracy * Receiving metered-dose inhaler therapy for \<6 months * Outpatient treatment * Being hospitalized in the intensive care unit * Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy) * Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy) * Not signing the informed consent form for participation in the study * Not having internet access and a mobile device with Android/iOS operating system * Not having telephone skills * Having communication barriers * Requiring assistance while using the inhaler * Not making any errors in the usage steps according to the MDI usage skills chart * Wanting to withdraw from the study/withdrawing from participation during the research process * Not completing the questionnaire

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elderly (people aged 65 or more) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Elderly (people aged 65 or more) Elderly patients receiving metered dose inhaler therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University

    RECRUITING

    Çanakkale, 17100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.